This webcast has already been broadcasted.


Having the right system requirements means you don’t miss out on the webcast.

  1. Have you logged in using your Healthed account details?
    For computer – the blue Login button is at the top right hand corner of the screen. On smaller screens – the blue Login button is in the menu at the top left hand corner of the screen.
  2. Make sure your internet speed is 5mbps or higher.
    Go to to test your internet speed.
  3. Suitable browsers
    The webcast is best viewed on Google Chrome, Microsoft Edge, Firefox, Safari or Opera.
  4. System Requirement
    If you are watching the webcast at your practice or workplace or using an equipment provided by your employer, restrictions and blockers may be installed which prevent the webcast from streaming. To check your device, play the webcast preview by clicking on the Hot Topics Webcast window above. Also check that your speakers are connected.

If the webcast preview does not play, please use another device or watch the webcast at another location.

About Healthed webcasts

Healthed webcasts are a valuable educational platform, allowing viewers to gain up-to-date clinical knowledge through an easy, time-efficient format. Our free web-based seminars fill a huge unmet need amongst GPs outside of the major cities for quality, accessible education. Every Healthed webcast features at least three expert lectures and runs for at least 90 minutes. While the majority of our viewers are General Practitioners, our webcasts are also drawing growing interest from other HCPs, such as pharmacists and nurses. Registrants can watch stream the webcast on a computer, tablet or phone. Instructions on how to log in to the webcast will be emailed to registered delegates in the weeks before the event.

Healthed Webcast – 31st August 2021


Aug, 2021

6:30 pm - 9:30 pm | AEST

This webcast has already been broadcasted.

Topics & Speaker

The New Zoster Vaccine – More Effective Conversations & Practice Systems

Dr Lisa Beecham

General Practitioner; Director, Immunisation Committee, Gold Coast Primary Health Network

Topic summary
A new herpes zoster vaccine is now available in Australia. In this presentation, Dr Lisa Beecham will explain the key differences between this new vaccine against shingles and what is currently available, and who might be best to be offered this option. She will also present the key reasons why patients might be convinced to pay for this otherwise unfunded vaccine.

COVID Update

Prof Kristine Macartney

Professor, Paediatrics & Child Health, Children's Hospital, Westmead, Vaccinologist, Director, National Centre for Immunisation Research & Surveillance (NCIRS)

Professor Kristine Macartney is a paediatrician specialising in infectious diseases and vaccinology. She is a medical graduate of the University of New South Wales and undertook her specialty training in Sydney and in the United States at the Children’s Hospital of Philadelphia. Her Doctorate of Medicine was on rotavirus infection, in particular the mucosal immune response to novel vaccine candidates. She was a foundational member of the Vaccine Education Center at the Children’s Hospital of Philadelphia. Kristine is currently the Director of the National Centre for Immunisation Research and Surveillance (NCIRS), a paediatric infectious disease consultant at The Children’s Hospital at Westmead and a Professor in the Discipline of Paediatrics and Child Health, University of Sydney. Her research interests include translation of evidence into policy and practice, vaccine safety, and most other areas of vaccine preventable diseases research, particularly in relation to rotavirus, varicella zoster virus and influenza. She is the senior editor of the Australian Immunisation Handbook (9th and10th Editions and online) and has authored >130 peer-reviewed publications. She is a member of the Advisory Committee on Vaccines (ACV) of the Therapeutic Goods Administration (TGA), the Communicable Diseases Network of Australia (CDNA) and the Australian Technical Advisory Group on Immunisation (ATAGI). She has acted as an expert consultant to the World Health Organisation (WHO). She also leads the Australian national AusVaxSafety and Paediatric Active Enhanced Disease Surveillance (PAEDS) networks, and is the founding chair of the Australian Regional Immunisation Alliance (ARIA).
Topic summary
The Delta variant is proving to be a game-changer in the fight against COVID-19. Its high and seemingly indiscriminate infectivity has seen a huge surge in people requesting vaccination against the virus, particularly with the Pfizer vaccine. GPs are at the frontline, they are a major part of the solution. More than ever, GPs need to be across the latest in all aspects of COVID-19 and the vaccines available to combat this pandemic. In this webcast, Healthed will deliver answers from Australian experts on the important issues GPs need to know in order to stay up to speed in the war against this deadly and ubiquitous virus.

Strategies to Mitigate Cognitive Decline and Early Dementia

A/Prof Michael Woodward

Consultant Geriatrician; Head of Aged Care and Memory Clinic, Austin Health

Topic summary
Mild cognitive impairment is not just a natural consequence of ageing. According to Associate Professor Michael Woodward, mild cognitive impairment is a critical diagnosis to make, not just because it can be a precursor to Alzheimer's disease but because it can represent an opportunity for intervention which can, at the very least slow the older person's progression to dementia and may, in some cases even prevent it.

Human Milk Oligosaccharides in Infant Formula – Practical Implications of this New Development 

A/Prof Avi Lemberg

Paediatric Gastroenterologist; Head of Paediatric Gastroenterology, Sydney Children’s Hospital

Dr Lemberg is a paediatric gastroenterologist with 15 years of experience in the management of children with gastrointestinal diseases. He was appointed Head of Paediatric Gastroenterology at Sydney Children’s Hospital in 2009 and is also Director of the Children’s Inflammatory Bowel Diseases Clinic (IBD) at The Sydney Children’s Hospital. He has clinical research interests in IBD, Probiotics, Gut Bacteria, Coeliac disease and Eosinophilic Oesophagitis (EoE)/Gut allergy and has published more than 100 peer reviewed publications and book chapters.
Topic summary
Human milk oligosaccharides (HMOs) are one of the major differences between human milk and formula milk. Current evidence demonstrates their multiple beneficial effects including antimicrobial, immune modulation, prebiotic, neurodevelopment and cognition effects. Recently, manufactured HMOs have been approved as food ingredients with fascinating implications for infant formula. This lecture will explore the potential of HMOs to make infant formula a more beneficial alternative when human breast milk is inadequate or unavailable.

This webcast has already been broadcasted.